BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2860288)

  • 21. Progress in the medicinal chemistry of the herb feverfew.
    Groenewegen WA; Knight DW; Heptinstall S
    Prog Med Chem; 1992; 29():217-38. PubMed ID: 1475370
    [No Abstract]   [Full Text] [Related]  

  • 22. Compounds extracted from feverfew that have anti-secretory activity contain an alpha-methylene butyrolactone unit.
    Groenewegen WA; Knight DW; Heptinstall S
    J Pharm Pharmacol; 1986 Sep; 38(9):709-12. PubMed ID: 2877077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of feverfew on phagocytosis and killing of Candida guilliermondii by neutrophils.
    Williamson LM; Harvey DM; Sheppard KJ; Fletcher J
    Inflammation; 1988 Feb; 12(1):11-6. PubMed ID: 3366482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bioassay for inhibition of serotonin release from bovine platelets.
    Marles RJ; Kaminski J; Arnason JT; Pazos-Sanou L; Heptinstall S; Fischer NH; Crompton CW; Kindack DG; Awang DV
    J Nat Prod; 1992 Aug; 55(8):1044-56. PubMed ID: 1431933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition.
    Sahler J; Bernard JJ; Spinelli SL; Blumberg N; Phipps RP
    Thromb Res; 2011 May; 127(5):426-34. PubMed ID: 21272923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feverfew: chemistry and biological activity.
    Knight DW
    Nat Prod Rep; 1995 Jun; 12(3):271-6. PubMed ID: 7792073
    [No Abstract]   [Full Text] [Related]  

  • 28. Stimulated platelets release factor(s) affecting the in vitro response of human polymorphonuclear cells.
    Del Principe D; Menichelli A; Di Giulio S; De Matteis W; Giordani M; Pentassuglio AM; Finazzi-Agro A
    J Leukoc Biol; 1990 Jul; 48(1):7-14. PubMed ID: 2113564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism.
    Srivastava KC
    Biomed Biochim Acta; 1984; 43(8-9):S335-46. PubMed ID: 6440548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
    Wu C; Chen F; Rushing JW; Wang X; Kim HJ; Huang G; Haley-Zitlin V; He G
    J Med Food; 2006; 9(1):55-61. PubMed ID: 16579729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor-mediated stimuli.
    Brom C; Brom J; König W
    Immunology; 1991 Jul; 73(3):287-92. PubMed ID: 1652553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium ionophore A23187 induces release of chemokinetic and aggregating factors from polymorphonuclear leucocytes.
    Bray MA; Ford-Hutchinson AW; Shipley ME; Smith MJ
    Br J Pharmacol; 1980; 71(2):507-12. PubMed ID: 6781577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
    Majdi M; Liu Q; Karimzadeh G; Malboobi MA; Beekwilder J; Cankar K; Vos Rd; Todorović S; Simonović A; Bouwmeester H
    Phytochemistry; 2011 Oct; 72(14-15):1739-50. PubMed ID: 21620424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracts of feverfew inhibit mitogen-induced human peripheral blood mononuclear cell proliferation and cytokine mediated responses: a cytotoxic effect.
    O'Neill LA; Barrett ML; Lewis GP
    Br J Clin Pharmacol; 1987 Jan; 23(1):81-3. PubMed ID: 3493021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1974 Nov; 77(2):135-49. PubMed ID: 4374890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of Rubus idaeus and Rubus caesius leaf extracts on platelet aggregation in whole blood. Cross-talk of platelets and neutrophils.
    Dudzinska D; Bednarska K; Boncler M; Luzak B; Watala C
    Platelets; 2016 Jul; 27(5):433-9. PubMed ID: 26836594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A chloroform extract of the herb feverfew blocks voltage-dependent potassium currents recorded from single smooth muscle cells.
    Barsby RW; Knight DW; McFadzean I
    J Pharm Pharmacol; 1993 Jul; 45(7):641-5. PubMed ID: 8105061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chrysanthemum dermatitis in South Wales; diagnosis by patch testing with feverfew (Tanacetum parthenium) extract.
    Schmidt RJ; Kingston T
    Contact Dermatitis; 1985 Aug; 13(2):120-1. PubMed ID: 4064647
    [No Abstract]   [Full Text] [Related]  

  • 40. Melatonin in feverfew and other medicinal plants.
    Murch SJ; Simmons CB; Saxena PK
    Lancet; 1997 Nov; 350(9091):1598-9. PubMed ID: 9393344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.